28
Oct
2025

CNX Therapeutics Ltd

Exhibitor at CPHI Frankfurt 2025 stand 3.1D50, Finished Dosage Formulations
About Us

CNX Therapeutics is a European speciality pharma company improving patients' lives through a portfolio of essential medicines in CNS, critical care, and other vital areas. In recent years, we've expanded rapidly through strategic acquisitions and partnerships, now operating in over 60 markets worldwide.

In addition to delivering essential medicines to patients, our work is guided by a commitment to sustainability and doing what’s right for patients, our team, and the planet.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • GB
  • 2023
    On CPHI since
  • 1
    Certificates
  • 25 - 49
    Employees
Company types
Pharmaceutical company
Primary activities
Other
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.1D50, Finished Dosage Formulations